Loading...
Home2024-10-23T15:47:52+00:00

ABOUT US

Nanostics is a commercial-stage precision health company developing novel tools to help bring clarity to healthcare decisions.

De-risking prostate cancer screening with ClarityDX Prostate

ClarityDX Prostate builds upon the utility of clinical features and blood-based biomarkers to determine a patient’s risk of having aggressive prostate cancer. This empowers patients and their healthcare providers make more informed healthcare decisions. 

Dr. John Lewis

Dr. John Lewis

CEO of Nanostics and Bird Dogs Chair of Translational Oncology at the University of Alberta

After over a decade of collaboration and innovation, powered by the generosity of so many, Nanostics has developed ClarityDX Prostate, a breakthrough that substantially enhances the prediction of aggressive prostate cancer and reduces the number of prostate biopsies, which are invasive, uncomfortable and carry some risk.

Recent News

2024 PROSTATE CANCER SCREENING UPDATE

Our success is possible thanks to the support of our many Canadian and international collaborators, funders, and partners.

Alberta Precision Laboratory

Follow Us

Follow us in real-time to learn about our products and what’s in the developmental pipeline.

Contact Us

Nanostics clinical laboratory is located at 10150 102 Street, Edmonton, AB, Canada.

Hours: 9 am – 5 pm Monday to Friday

If you have questions or concerns please contact us by telephone or email. We will respond within 1 to 2 business days.

Telephone: 1-800-672-2027

  • Press 1 to connect with the Clinical Laboratory

  • Press 2 for help with ordering your ClarityDX Prostate test

  • Press 3 for General Inquiries.

Email [email protected] or submit a message in the Contact Us box to the right.

We value your privacy, please read our policy here: Nanostics Privacy Policy

    © Copyright 2024 Nanostics | Designed by Forward Momentum | Powered by WordPress

    Go to Top